{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:23:06Z","timestamp":1762867386515,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Social Science Foundation","doi-asserted-by":"crossref","award":["14BTQ036"],"award-info":[{"award-number":["14BTQ036"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12911-018-0599-5","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T13:03:45Z","timestamp":1520600625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Traditional Chinese medicine pharmacovigilance in signal detection: decision tree-based data classification"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9052-9212","authenticated-orcid":false,"given":"Jian-Xiang","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Xia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hou-Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"issue":"9237","key":"599_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255\u20139.","journal-title":"Lancet"},{"key":"599_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJW Evans","year":"2001","unstructured":"Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10:483\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"599_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2125.2003.01968.x","volume":"57","author":"AM Wilson","year":"2003","unstructured":"Wilson AM, Thabane L, Holbrook A. Application of data mining techniques in pharmacovigilance. J Clin Pharmacol. 2003;57(2):127\u201334.","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"599_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/00002018-200326050-00001","volume":"26","author":"EP Van Puijenbroek","year":"2003","unstructured":"Van Puijenbroek EP, Diemont WL, Grootheest K. Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions. Drug Saf. 2003;26(5):293\u2013301.","journal-title":"Drug Saf"},{"issue":"3","key":"599_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2165\/00002018-200326030-00003","volume":"26","author":"M Hauben","year":"2003","unstructured":"Hauben M, Zhou XF. Quantitative methods in pharmacovigilance: focus on signal detection. Drug Saf. 2003;26(3):159\u201386.","journal-title":"Drug Saf"},{"issue":"7","key":"599_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00002018-200730070-00011","volume":"30","author":"A Bate","year":"2007","unstructured":"Bate A. Bayesian confidence propagation neural network. Drug Saf. 2007;30(7):623\u20135.","journal-title":"Drug Saf"},{"issue":"6","key":"599_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2165\/00002018-200225060-00002","volume":"25","author":"A Bate","year":"2002","unstructured":"Bate A, Lindquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Saf. 2002;25(6):393\u20137.","journal-title":"Drug Saf"},{"key":"599_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54:315\u201321.","journal-title":"Eur J Clin Pharmacol"},{"key":"599_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","volume":"53","author":"W DuMouchel","year":"1999","unstructured":"DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999;53:177\u201390.","journal-title":"Am Stat"},{"issue":"7","key":"599_CR10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T, Tamon A, Kadoyama K, et al. Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci. 2013;10(7):796\u2013803.","journal-title":"Int J Med Sci"},{"key":"599_CR11","doi-asserted-by":"crossref","unstructured":"Li C, Xia J, Deng J, et al. A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China. Pharmacoepidemiol Drug Saf. 2008;17(6):593-600.","DOI":"10.1002\/pds.1601"},{"key":"599_CR12","first-page":"154","volume":"3","author":"J Jing","year":"2010","unstructured":"Jing J, Yongfang H, Xiujuan L, Jingtian R, Shaohong J. Application of different signal detection methods in ADR self-reporting systems in China. Chinese Journal of Pharmacovigilance. 2010;3:154\u20135.","journal-title":"Chinese Journal of Pharmacovigilance"},{"key":"599_CR13","first-page":"356","volume":"6","author":"R Jingtian","year":"2011","unstructured":"Jingtian R, Wang S, Yongfang H, Xiaoxi D, Liming L. Comparative research of common ADR signal detection methods. Chinese Journal of Pharmacovigilance. 2011;6:356\u20139.","journal-title":"Chinese Journal of Pharmacovigilance."},{"key":"599_CR14","first-page":"22","volume":"1","author":"J Wu","year":"2014","unstructured":"Wu J, Lin X, Lijun J, et al. Developmental status and case study of traditional Chinese medicine ADR monitoring. Pharmaceutical Analysis. 2014;1:22\u20135.","journal-title":"Pharmaceutical Analysis"},{"key":"599_CR15","unstructured":"Information on adverse drug reactions (No.44): a severe anaphylactic reaction to Shengmai injection. http:\/\/114.255.93.201\/xxtb_255\/ypblfyxxtb\/201201\/t20120111_4856.html . Accessed 6 Sep 2016."},{"issue":"12","key":"599_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2165\/00002018-200326120-00001","volume":"26","author":"J Barnes","year":"2003","unstructured":"Barnes J. Pharmacovigilance of herbal medicines : a UK perspective. Drug Saf. 2003;26(12):829\u201351.","journal-title":"Drug Saf"},{"key":"599_CR17","unstructured":"Tian YJ, Jiao B, Xie JZ, et al. The programming and application of analysis system for adverse drug reactions of traditional chinese medicine. Chin J Pharmacovigilance. 2007;4(4):217-21."},{"issue":"3","key":"599_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jep.2012.01.058","volume":"140","author":"L Zhang","year":"2012","unstructured":"Zhang L, Yan J, Liu X, et al. Pharmacovigilance practice and risk control of traditional Chinese medicine drugs in China: current status and future perspective. J Ethnopharmacol. 2012;140(3):519\u201325.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"599_CR19","first-page":"353","volume":"29","author":"A Bate","year":"2006","unstructured":"Bate A, Ericsson J, Farah M. International data mining for signals of herbal ADRs. Drug Saf. 2006;29(4):353.","journal-title":"Drug Saf"},{"issue":"1","key":"599_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EPV Puijenbroek","year":"2002","unstructured":"Puijenbroek EPV, Bate A, Leufkens HGM, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiology & Drug Safety. 2002;11(1):3\u201310.","journal-title":"Pharmacoepidemiology & Drug Safety"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-018-0599-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12911-018-0599-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-018-0599-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T22:22:33Z","timestamp":1719872553000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-018-0599-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1186\/s12911-018-0599-5","relation":{},"ISSN":["1472-6947"],"issn-type":[{"type":"electronic","value":"1472-6947"}],"subject":[],"published":{"date-parts":[[2018,3,9]]},"assertion":[{"value":"3 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"According to \u201cAdverse Drug Reaction Reporting and Monitoring Management Regulation\u201d (No.81 Order of Ministry of Health of China,), all ADR reports are collected by voluntary way. The ADR data in this paper was provided by CFDA and it did not contain individual information of the patients. For all studies mentioned in this manuscript, no approval of the ethical review board was needed according to \u201cEthical Review Involving Human Biomedical Research\u201d (No.11 Order of National Health and Family Planning Commission of China,); only human subject research with a high impact for patients have to be reviewed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"19"}}